Buspirone sustained-release 15 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Buspirone sustained-release 15 mg, covering 2022-06-24 to 2022-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo [Phase 3]